ArticleApplied biochemistry and biotechnology2025
Phytoconstituent Profiling and Antifungal Efficacy of Artemisia absinthium L.: Towards Sustainable Bio-Fungicide Development.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unveiling the multifaceted potential ofJournal of pharmaceutical analysis · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural alternatives to synthetic fungicides are gaining prominence as the focus sharpens on developing protective products. In this regard, the present study aimed to discern the antifungal potential of Artemisia absinthium L., a traditional medicinal plant native to Kashmir, by identifying its key phytoconstituents. Here, we present the notable antifungal activity of the leaf extract of A. absinthium against Fusarium oxysporum, Penicillium digitatum, and Alternaria solani, as observed through in vitro tests. Further refinement of the extract through chromatography isolated fraction 4 (F4), unveiling 27 compounds with no prior literature on their occurrence in A. absinthium. Additionally, in silico molecular docking analysis revealed three compounds which include Bruceine B (1), Guanidine, (phenylmethyl)- (2) and Ethyl alpha-d-glucoside (3) as potent inhibitors of multiple target key fungal enzymes such as endopolygalacturonase, chitin deacetylase and 1, 3, 8-trihydroxynaphthalene. The virtual screening unveiled compounds 1-3 within fraction 4, displaying robust binding energy ranging from -8 to -5.8 kcal/mol with multiple target enzymes. Notably, their efficacy surpassed that of the reference commercial fungicide, benodanil. This study underscores the burgeoning interest in harnessing natural alternatives for fungicidal applications, highlighting the potential of A. absinthium as a valuable resource in the quest for sustainable and effective bio-fungicides.
Indexed as
Identifiers
39115786What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.